Press

September 4, 2025

We purged worms from our bodies — and may have made ourselves sick

August 26, 2025

Dr. Andrea Choe, MD, Ph.D. – CEO, Holoclara – Worm-Derived Therapeutics For Debilitating Diseases

January 27, 2025

Parasites as Medicine? Dr. Andrea Choe on Immunomodulation & Autoimmune Disease | Ep. 16

December 18, 2024

Holoclara’s announcement entering Phase 1 clinical trials and targeting Eosinophilic esophagitis is featured in Fierce Biotech.

September 20, 2024

Holoclara’s first-in-class technology detailed in Forbes’ The Prototype.

August 9, 2024

Holoclara Announces Head of Research and Development Hire

July 23, 2024

Worm-Derived Therapeutics For Debilitating Diseases

June 27, 2024

Holoclara’s Series A Financing featured in exclusive Fortune coverage.

June 27, 2024

Holoclara announces $16M Series A Financing to advance a breakthrough class of worm-derived therapeutics for allergic and autoimmune disease.

June 21, 2024

Taking on Autoimmune Diseases—with Worms!

June 21, 2024

Holoclara CEO Andrea Choe participates in Aspen Ideas Festival.

June 20, 2024

Aspen Ideas: Health Opening Session

April 25, 2024

Holoclara BOD member Peter B Hutt featured in Wall Street Journal, honoring the legacy he is creating in Food and Drug Law.

March 26, 2024

CEO Andrea Choe participates in “Demystifying Aging” panel at Horizons Venture’s Techcracker Summit.

March 26, 2024

CEO Andrea Choe joins Solina Chau, Jennifer Doudna, and other entrepreneurs to discuss innovation with students at Tokyo Medical and Dental University.

March 15, 2024

Techcracker Lab 2024 – Andrea Choe, Founder & CEO of Holoclara

January 1, 2024

Holoclara Announces Business Operations Hire

June 26, 2021

Holoclara CEO Andrea Choe wins Emerging Women Founder Award.